GlassScriptPhysician profile
Jeffrey S Henn
NPI 1821064957
$236,964.58
in general payments reported to CMS, 2019-2025
25 companies · $8,475 in 2025
The $8,475 reported for 2025 was more than what 84% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73K · 2020: $21K · 2021: $24K · 2022: $25K · 2023: $50K · 2024: $35K · 2025: $8,475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $38K · Royalty Or License: $35K · Consulting Fee: $14K · Food and Beverage: $3,974 · Travel and Lodging: $1,835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $38,412.50 |
| Royalty Or License | $35,384.89 |
| Consulting Fee | $14,050.00 |
| Food and Beverage | $3,973.83 |
| Travel and Lodging | $1,834.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integrity Implants INC. | $77,070.06 | 2019-2022 | Flarehawk |
| Medacta USA, INC. | $59,849.36 | 2019-2020 | |
| Painteq LLC | $52,809.92 | 2022-2025 | Painteq |
| Integrity Implants INC. Dba Accelus | $35,417.56 | 2023-2024 | Flarehawk |
| Intrinsic Therapeutics | $5,892.79 | 2023-2025 | Barricaid Acd (Annular Closure Device) |
| Zimmer Biomet Holdings, INC. | $2,666.46 | 2019-2020 | |
| Alphatec Spine, INC | $1,105.00 | 2020-2021 | |
| Medtronic, INC. | $729.14 | 2022-2023 | Intellis Adaptivestim, Clydesdale Ptc Spinal System |
| Relievant Medsystems, INC. | $319.27 | 2021-2023 | Intracept |
| Depuy Synthes Sales INC. | $150.70 | 2020-2021 | |
| 4web, INC. | $149.80 | 2020 | |
| Vertos Medical, INC. | $144.23 | 2023 | Mild Device Kit |
| Boston Scientific Corporation | $138.54 | 2025 | General - Pain Management, General - Therapies |
| Smith+Nephew, INC. | $112.50 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Globus Medical, INC. | $107.30 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $58.11 | 2019 | |
| Nuvasive, INC. | $51.60 | 2019 | |
| Spinal Simplicity, LLC | $49.32 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $27.35 | 2025 | Exparel |
| Si-Bone, INC. | $25.85 | 2020 | |
| Baxter Healthcare | $22.55 | 2021 | |
| Baudax Bio INC. | $19.86 | 2020 | |
| Stryker Corporation | $19.67 | 2023 | Spinemap |
| Scilex Pharmaceuticals INC. | $15.97 | 2019 | |
| Endo Pharmaceuticals INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Henn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.